Clinuvel Pharmaceuticals Limited (ASX: CUV)
Australia
· Delayed Price · Currency is AUD 13.16
-0.24 (-1.79%)
Nov 21, 2024, 4:10 PM AEST
Clinuvel Pharmaceuticals Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 657 | 770 | 883 | 734 | 1,517 | 1,267 | Upgrade
|
| Market Cap Growth | -12.87% | -12.87% | 20.40% | -51.63% | 19.69% | -23.14% | Upgrade
|
| Enterprise Value | 474 | 596 | 744 | 636 | 1,445 | 1,210 | Upgrade
|
| Last Close Price | 13.16 | 15.32 | 17.77 | 14.73 | 30.43 | 25.39 | Upgrade
|
| PE Ratio | 18.85 | 21.60 | 28.87 | 35.14 | 61.34 | 84.20 | Upgrade
|
| Forward PE | 18.38 | 21.49 | 28.34 | 26.11 | 78.02 | 94.30 | Upgrade
|
| PS Ratio | 7.44 | 8.73 | 11.28 | 11.16 | 31.39 | 38.92 | Upgrade
|
| PB Ratio | 3.25 | 3.79 | 5.37 | 5.84 | 15.36 | 17.59 | Upgrade
|
| P/TBV Ratio | 3.80 | 3.80 | 5.37 | 5.85 | 15.39 | 17.63 | Upgrade
|
| P/FCF Ratio | 20.88 | 24.45 | 24.62 | 18.61 | 82.41 | 95.29 | Upgrade
|
| P/OCF Ratio | 20.77 | 20.77 | 23.93 | 18.40 | 78.75 | 89.32 | Upgrade
|
| EV/Sales Ratio | 5.38 | 6.76 | 9.50 | 9.68 | 29.91 | 37.16 | Upgrade
|
| EV/EBITDA Ratio | 9.55 | 12.09 | 16.71 | 17.68 | 49.73 | 97.48 | Upgrade
|
| EV/EBIT Ratio | 9.77 | 12.28 | 16.86 | 17.89 | 50.60 | 98.79 | Upgrade
|
| EV/FCF Ratio | 15.07 | 18.95 | 20.73 | 16.12 | 78.52 | 91.00 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.10 | Upgrade
|
| Debt / FCF Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.07 | 0.10 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.46 | 0.52 | 0.51 | 0.45 | Upgrade
|
| Inventory Turnover | 0.77 | 0.77 | 1.33 | 3.69 | 1.87 | 4.26 | Upgrade
|
| Quick Ratio | 8.33 | 8.33 | 7.02 | 10.03 | 11.34 | 8.88 | Upgrade
|
| Current Ratio | 8.81 | 8.81 | 7.44 | 10.24 | 11.81 | 9.10 | Upgrade
|
| Return on Equity (ROE) | 19.39% | 19.39% | 21.09% | 18.62% | 28.95% | 23.29% | Upgrade
|
| Return on Assets (ROA) | 14.29% | 14.29% | 16.34% | 17.60% | 18.78% | 10.64% | Upgrade
|
| Return on Capital (ROIC) | 16.43% | 16.43% | 18.86% | 19.59% | 20.59% | 11.69% | Upgrade
|
| Earnings Yield | 5.30% | 4.63% | 3.46% | 2.85% | 1.63% | 1.19% | Upgrade
|
| FCF Yield | 4.79% | 4.09% | 4.06% | 5.37% | 1.21% | 1.05% | Upgrade
|
| Dividend Yield | 0.37% | 0.33% | 0.28% | 0.27% | 0.08% | 0.10% | Upgrade
|
| Payout Ratio | 6.93% | 6.93% | 6.46% | 5.92% | 5.00% | 8.13% | Upgrade
|
| Buyback Yield / Dilution | 1.52% | 1.52% | -0.08% | -1.26% | -1.33% | -1.73% | Upgrade
|
| Total Shareholder Return | 1.90% | 1.85% | 0.20% | -0.99% | -1.25% | -1.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.